Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial (Q43774257)
scientific article published on 4 January 2010
Language:
(P31) (Q13442814)
(P50) (Q43028563)
(Q32649390)
(Q32649861)
(P304) 841-846
(P407) (Q1860)
(P433) 5
(P478) 28
(P577) Monday, January 4, 2010
(P921) (Q42824827)
(P1433) (Q400292)
(P1476) "Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial" (language: en)
(P2093) Michael Weichenthal
Knuth Rass
Ruthild Linse
Carola Berking
Jörg Böttjer
Thomas Vogt
Konstanze Spieth
Norbert H Brockmeyer
Annette Stein
Helmut Näher
Peter Mohr
Martin Kaatz
Michael Tronnier
Rüdiger Hein
Gerold Schuler
Friederike Egberts
Claus Garbe
other details
description scientific article published on 4 January 2010

External Links